After Hours
$
145.00
Change
-0.18 -0.12%
Volume
Volume 80,983
Oct 28, 2016, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 160.57
$ 145.18
Change
-15.39 -9.58%
Day low
Day high
$142.64
$151.76
52 week low
52 week high
$139.02
$176.85
Market cap
$108.65B
Average volume
3.00M
P/E ratio
14.49
Rev. per Employee
$1.25M
EPS
10.02
Dividend
1.00
Div yield
2.76%
Ex dividend date
11/14/16
MarketWatch News on AMGN
-
11 improving health-care companies whose stocks are loved by analysts
- Philip van Doorn
-
AbbVie tops profit views, but Humira sales miss
- MarketWatch.com
-
Amgen beats profit expectations and raises its outlook
- Tomi Kilgore
-
Amgen's stock falls 1.2% in after-hours trade after Q3 results
- Tomi Kilgore
-
Amgen raises 2016 adj. EPS outlook to $11.40-$11.55 from $11.10-$11.40; FactSet consensus $11.36
- Tomi Kilgore
-
Amgen revises 2016 revenue outlook to $22.6 bln-$22.8 bln; FactSet consensus $22.8 bln
- Tomi Kilgore
-
Amgen Q3 Neulasta sales $1.20 bln vs. $1.27 bln; FactSet consensus $1.17 bln
- Tomi Kilgore
-
Amgen Q3 Enbrel sales $1.45 bln vs. $1.46 bln; FactSet consensus $1.49
- Tomi Kilgore
-
Amgen Q3 revenue $5.81 bln vs. $5.72 bln; FactSet consensus $5.73 bln
- Tomi Kilgore
-
Amgen Q3 adj. EPS $3.02; FactSet consensus $2.79
- Tomi Kilgore
-
Amgen Q3 EPS $2.68 vs. $2.44 a year ago
- Tomi Kilgore
-
$147 billion mutual fund’s performance makes a case for active management
- Philip van Doorn
-
Index funds can be inferior to active funds in two crucial ways
- Philip van Doorn
-
What to expect from Novartis earnings
- MarketWatch.com
-
Biotech stocks have plenty of catalysts around the corner
- Michael Brush
-
Arrowhead shares halted premarket for Amgen news
- Ciara Linnane
-
Arrowhead to receive further up to $617 mln in milestone and equity payments
- Ciara Linnane
- Loading more headlines...
Where does this data come from?
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Sentiment on AMGN
Analyst Ratings
Other News on AMGN
-
6 Companies That Destroyed Shareholders Last Week
- 247WallSt.com
-
Stocks Rattled by Clinton Email Review
- The Wall Street Journal Interactive Edition
-
Why Amgen, McKesson, and Stonemor Partners Slumped Today
- Motley Fool
-
Backlash Against Drug Prices Hits Manufacturers and Middlemen
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
5 Things Amgen Inc.'s Management Wants You to Know
- Motley Fool
-
Biogen Reported a Positive Financial Performance in 3Q16
- MarketRealist.com
-
Stocks Are Choppy as FBI Reopens Probe Into Clinton Emails
- TheStreet.com
-
No. 1 Biotech Amgen Dives As Rebates Chip Away At 2017 Sales View
- Investors Business Daily
-
Biotechs Pounded While Market Sits In A Holding Pattern
- Seeking Alpha
-
AbbVie Topples On Humira Miss; Sanofi, Novo Diverge On Insulin Panic
- Investors Business Daily
-
Keytruda: The New Blockbuster of Merck’s Immuno-Oncology Franchise
- MarketRealist.com
-
Week In Review: Apple, Amazon, Alphabet Are A-Listers On Crowded Earnings Stage
- Investors Business Daily
-
Health ETFs Fall; Trading Sentiment Is Both Bullish And Bearish
- Investors Business Daily
- Loading more headlines...
Earnings Announcement
-
Amgen (AMGN) Q3 2016 Results - Earnings Call Transcript
- Seeking Alpha
Press Releases on AMGN
-
UNITY Biotechnology Announces $116 Million Series B Financing
- PR Newswire - PRF
-
Amgen To Invest In Israel-Based eHealth Ventures
- PR Newswire - PRF
-
Amgen Announces Webcast Of 2016 Third Quarter Financial Results
- PR Newswire - PRF
-
Unilife Announces Filing of 2016 10-K
- PR Newswire - PRF
-
Amgen Announces 2016 Fourth Quarter Dividend
- PR Newswire - PRF
-
Amgen Announces Appointment Of Ellen J. Kullman To Board Of Directors
- PR Newswire - PRF
-
Boeing Board Elects Amgen CEO Bradway as New Director
- PR Newswire - PRF
-
- PR Newswire - PRF
-
Amgen Foundation Donates $25K to Curriki
- Marketwired
-
Market Access Impact: Renal Cell Carcinoma (EU5)
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Low Interest | 12.00% | 12.00% | 11.96% |
| Business | 13.12% | 13.12% | 13.12% |
| Student | 13.42% | 13.42% | 13.42% |
| Balance Transfer | 14.41% | 14.41% | 14.39% |
| Airline | 15.13% | 15.13% | 15.17% |
| Reward | 15.24% | 15.24% | 15.30% |
| Cash Back | 15.33% | 15.33% | 15.30% |
| Instant Approval | 17.86% | 17.86% | 18.04% |
| Bad Credit | 22.86% | 22.86% | 22.56% |




